1,3-ditolylguanidine has been researched along with Seizures in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Franklin, PH; Murray, TF; Roth, JE | 1 |
| Kesingland, AC; Singh, L; Tricklebank, MD; Wong, EH | 1 |
2 other study(ies) available for 1,3-ditolylguanidine and Seizures
| Article | Year |
|---|---|
The sigma receptor ligand 1,3-di(2-tolyl)guanidine is anticonvulsant in the rat prepiriform cortex.
Topics: Animals; Anticonvulsants; Bicuculline; Brain; Drug Interactions; Guanidines; Haloperidol; Male; Rats; Rats, Sprague-Dawley; Receptors, sigma; Seizures | 1993 |
Evidence against an involvement of the haloperidol-sensitive sigma recognition site in the discriminative stimulus properties of (+)-N-allylnormetazocine ((+)-SKF 10,047).
Topics: Animals; Aspartic Acid; Binding, Competitive; Dibenzocycloheptenes; Discrimination, Psychological; Dizocilpine Maleate; Guanidines; Haloperidol; Male; Mice; N-Methylaspartate; Phenazocine; Rats; Rats, Inbred Strains; Receptors, Opioid; Receptors, Opioid, delta; Seizures | 1990 |